Can Fite Biopharma Stock Price on April 26, 2024
| CANF Stock | USD 2.20 0.10 4.76% |
Below is the normalized historical share price chart for Can Fite Biopharma extending back to November 01, 2012. This chart has been adjusted for all splits and dividends and is plotted against all major global economic recessions. As of today, the current price of Can Fite stands at 2.20, as last reported on the 1st of December, with the highest price reaching 2.28 and the lowest price hitting 2.14 during the day.
If you're considering investing in Can Stock, it is important to understand the factors that can impact its price. At this point, Can Fite is moderately volatile. Can Fite Biopharma secures Sharpe Ratio (or Efficiency) of 0.0163, which signifies that the company had a 0.0163% return per unit of risk over the last 3 months. We have found thirty technical indicators for Can Fite Biopharma, which you can use to evaluate the volatility of the firm. Please confirm Can Fite's Downside Deviation of 3.41, mean deviation of 2.84, and Risk Adjusted Performance of 0.0091 to double-check if the risk estimate we provide is consistent with the expected return of 0.0666%.
At this time, Can Fite's Common Stock is most likely to increase significantly in the upcoming years. The Can Fite's current Stock Based Compensation is estimated to increase to about 350.5 K, while Total Stockholder Equity is projected to decrease to roughly 5.6 M. . The Can Fite's current Price Earnings To Growth Ratio is estimated to increase to 0.02, while Price To Sales Ratio is projected to decrease to 12.14. Can Stock price history is provided at the adjusted basis, taking into account all of the recent filings.
IPO Date 6th of November 2012 | 200 Day MA 2.407 | 50 Day MA 2.2146 | Beta 0.567 |
Can |
Sharpe Ratio = 0.0163
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ||||
| Cash | Small Risk | Average Risk | CANF | Huge Risk |
| Negative Returns |
Estimated Market Risk
| 4.09 actual daily | 36 64% of assets are more volatile |
Expected Return
| 0.07 actual daily | 1 99% of assets have higher returns |
Risk-Adjusted Return
| 0.02 actual daily | 1 99% of assets perform better |
Based on monthly moving average Can Fite is performing at about 1% of its full potential. If added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Can Fite by adding it to a well-diversified portfolio.
Price Book 5.4103 | Enterprise Value Ebitda 0.0965 | Price Sales 20.2198 | Shares Float 1.7 B | Wall Street Target Price 13.3333 |
Related Headline
Adial Pharmaceuticals Headline on 26th of April 2024
Acquisition by Newman James W. Jr. of 10000 shares of Adial ... by Newman James W. Jr.
Filed transaction by Adial Pharmaceuticals Director. Grant, award or other acquisition pursuant to Rule 16b-3
Can Fite Valuation on April 26, 2024
It is possible to determine the worth of Can Fite on a given historical date. On April 26, 2024 Can was worth 2.0 at the beginning of the trading date compared to the closed value of 1.98. We use multiple weighted factors in our valuation methodologies to arrive at the intrinsic value of Can Fite stock. Still, in general, we apply an absolute valuation method to find Can Fite's value based on its fundamental and technical indicators available within our service. As compared to an absolute model, our relative valuation model uses a comparative analysis of Can Fite where we calculate exposure to its market risk and evaluate relevant financial multiples and ratios against Can Fite's related companies.
| Open | High | Low | Close | Volume | |
| 1.94 | 1.97 | 1.91 | 1.92 | 12,346 | |
04/26/2024 | 2.00 | 2.01 | 1.91 | 1.98 | 8,665 |
| 1.98 | 2.02 | 1.95 | 1.97 | 8,739 |
| Backtest Can Fite | | | Can Fite History | | | Can Fite Valuation | Previous | Next |
Can Fite Trading Date Momentum on April 26, 2024
| On April 29 2024 Can Fite Biopharma was traded for 1.97 at the closing time. The top price for the day was 2.02 and the lowest listed price was 1.95 . The trading volume for the day was 8.7 K. The trading history from April 29, 2024 was a factor to the next trading day price decrease. The overall trading delta against the next closing price was 0.51% . The overall trading delta against the current closing price is 17.17% . |
Can Fite Biopharma Fundamentals Correlations and Trends
By evaluating Can Fite's financials over time, investors can gain insight into future company performance. However, you can also analyze the published financial statements to find patterns among Can Fite's main balance sheet or income statement drivers and many other relevant indicators that can statistically be found significantly correlated or uncorrelated. Can financial account trend analysis is a perfect complement when working with valuation or volatility modules.About Can Fite Stock history
Can Fite investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for Can is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in Can Fite Biopharma will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing Can Fite stock prices may prove useful in developing a viable investing in Can Fite
| Last Reported | Projected for Next Year | ||
| Common Stock Shares Outstanding | 4.3 M | 4 M | |
| Net Loss | -11.7 M | -12.3 M |
Can Fite Quarterly Net Working Capital |
|
Can Fite Stock Technical Analysis
Can Fite technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
Price Boundaries
Can Fite Period Price Range
Low | December 1, 2024
| High |
0.00 | 0.00 |
Can Fite Biopharma cannot be verified against its exchange. Please verify the symbol is currently traded on NYSE MKT Exchange. If you still believe the symbol you are trying to look up is valid, please let us know, and we will check it as soon as possible.
Can Fite December 1, 2024 Market Strength
Market strength indicators help investors to evaluate how Can Fite stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Can Fite shares will generate the highest return on investment. By undertsting and applying Can Fite stock market strength indicators, traders can identify Can Fite Biopharma entry and exit signals to maximize returns
Can Fite Technical and Predictive Indicators
Predictive indicators are helping investors to find signals for Can Fite's price direction in advance. Along with the technical and fundamental analysis of Can Stock historical price patterns, it is also worthwhile for investors to track various predictive indicators of Can to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.
| Risk Adjusted Performance | 0.0091 | |||
| Jensen Alpha | (0.11) | |||
| Total Risk Alpha | (0.68) | |||
| Sortino Ratio | (0.04) | |||
| Treynor Ratio | (0.01) |
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
Complementary Tools for Can Stock analysis
When running Can Fite's price analysis, check to measure Can Fite's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Can Fite is operating at the current time. Most of Can Fite's value examination focuses on studying past and present price action to predict the probability of Can Fite's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Can Fite's price. Additionally, you may evaluate how the addition of Can Fite to your portfolios can decrease your overall portfolio volatility.
| Options Analysis Analyze and evaluate options and option chains as a potential hedge for your portfolios | |
| Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Portfolio Comparator Compare the composition, asset allocations and performance of any two portfolios in your account | |
| Piotroski F Score Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals | |
| Portfolio Diagnostics Use generated alerts and portfolio events aggregator to diagnose current holdings | |
| Commodity Directory Find actively traded commodities issued by global exchanges | |
| Positions Ratings Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| CEOs Directory Screen CEOs from public companies around the world | |
| Portfolio Suggestion Get suggestions outside of your existing asset allocation including your own model portfolios |